St. Jude Medical Inc. is on pace to meet or exceed its previous 2013 revenue target for its cardiac rhythm management devices business, the company announced during its July 17 second-quarter earnings call.
The CRM business includes all of St. Jude’s pacemakers and implantable cardioverter defibrillator product lines.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?